223 related articles for article (PubMed ID: 36149152)
1. Comparative evaluation of immunohistochemical expression of MCM2 and Ki67 in oral epithelial dysplasia and oral squamous cell carcinoma.
Swain S; Nishat R; Ramachandran S; Raghuvanshi M; Behura SS; Kumar H
J Cancer Res Ther; 2022; 18(4):997-1002. PubMed ID: 36149152
[TBL] [Abstract][Full Text] [Related]
2. Expression of Mcm2, geminin and Ki67 in normal oral mucosa, oral epithelial dysplasias and their corresponding squamous-cell carcinomas.
Torres-Rendon A; Roy S; Craig GT; Speight PM
Br J Cancer; 2009 Apr; 100(7):1128-34. PubMed ID: 19293805
[TBL] [Abstract][Full Text] [Related]
3. Ki-67 Prognostic Value in Different Histological Grades of Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma.
Takkem A; Barakat C; Zakaraia S; Zaid K; Najmeh J; Ayoub M; Seirawan MY
Asian Pac J Cancer Prev; 2018 Nov; 19(11):3279-3286. PubMed ID: 30486632
[TBL] [Abstract][Full Text] [Related]
4. DNA replication licensing factor MCM2, geminin, and Ki67 define proliferative state and are linked with survival in oral squamous cell carcinoma.
Al-Hazmi N; Alhazzazi T; Williams G; Stoeber K; Al-Dabbagh R
Eur J Oral Sci; 2018 Jun; 126(3):186-196. PubMed ID: 29745471
[TBL] [Abstract][Full Text] [Related]
5. Aberrant expression of minichromosome maintenance proteins 2 and 5, and Ki-67 in dysplastic squamous oesophageal epithelium and Barrett's mucosa.
Going JJ; Keith WN; Neilson L; Stoeber K; Stuart RC; Williams GH
Gut; 2002 Mar; 50(3):373-7. PubMed ID: 11839717
[TBL] [Abstract][Full Text] [Related]
6. Ki-67 Expression as a Prognostic Marker: A Comparative Immunohistochemical Analysis of Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma.
Gupta V; Ramalingam K; Yasothkumar D; Debnath D; Sundar V
Cureus; 2023 May; 15(5):e38941. PubMed ID: 37313057
[TBL] [Abstract][Full Text] [Related]
7. Expression of minichromosome maintenance 2 (MCM2), Ki-67, and cell-cycle-related molecules, and apoptosis in the normal-dysplasia-carcinoma sequence of the oral mucosa.
Kodani I; Shomori K; Osaki M; Kuratate I; Ryoke K; Ito H
Pathobiology; 2001; 69(3):150-8. PubMed ID: 11872961
[TBL] [Abstract][Full Text] [Related]
8. Cell kinetic markers in cutaneous squamous and basal cell carcinoma of the head and neck.
Alaeddini M; Etemad-Moghadam S
Braz J Otorhinolaryngol; 2022; 88(4):529-532. PubMed ID: 32972865
[TBL] [Abstract][Full Text] [Related]
9. Expression of Ki-67 in normal oral epithelium, leukoplakic oral epithelium and oral squamous cell carcinoma.
Birajdar SS; Radhika M; Paremala K; Sudhakara M; Soumya M; Gadivan M
J Oral Maxillofac Pathol; 2014 May; 18(2):169-76. PubMed ID: 25328294
[TBL] [Abstract][Full Text] [Related]
10. MUC4 Expression in Oral Dysplastic Epithelium and Oral Squamous Cell Carcinoma: An Immunohistochemical Study.
Abidullah M; Nahar P; Ahmed SA; Kothari H; Vakeel S
J Int Soc Prev Community Dent; 2023; 13(2):124-132. PubMed ID: 37223448
[TBL] [Abstract][Full Text] [Related]
11. Assessment of cellular proliferation in oral verrucous carcinoma and well-differentiated oral squamous cell carcinoma using Ki67: a non-reliable factor for differential diagnosis?
Zargaran M; Eshghyar N; Baghaei F; Moghimbeigi A
Asian Pac J Cancer Prev; 2012; 13(11):5811-5. PubMed ID: 23317261
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical expression of Bcl-2 in oral epithelial dysplasia and oral squamous cell carcinoma.
Juneja S; Chaitanya NB; Agarwal M
Indian J Cancer; 2015; 52(4):505-10. PubMed ID: 26960459
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical evaluation of E-cadherin in oral epithelial dysplasia and squamous cell carcinoma.
Sharma J; Bhargava M; Aggarwal S; Aggarwal A; Varshney A; Chopra D
Indian J Pathol Microbiol; 2022; 65(4):755-760. PubMed ID: 36308176
[TBL] [Abstract][Full Text] [Related]
14. An Immunohistochemical Study Showing Ki-67 as an Analytical Marker in Oral Malignant and Premalignant Lesions.
Dash KC; Mahapatra N; Bhuyan L; Panda A; Behura SS; Mishra P
J Pharm Bioallied Sci; 2020 Aug; 12(Suppl 1):S274-S278. PubMed ID: 33149470
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemistry of YAP and dNp63 and survival analysis of patients bearing precancerous lesion and oral squamous cell carcinoma.
Ono S; Nakano K; Takabatake K; Kawai H; Nagatsuka H
Int J Med Sci; 2019; 16(5):766-773. PubMed ID: 31217745
[No Abstract] [Full Text] [Related]
16. Evaluation of CK19 and VEGF gene expression, ki67 antigen, p53 protein, C-erb-B2, and their relationship in oral squamous cell carcinoma.
Shen Y; Xu Z; Liu M; Piao S; Li J
Cell Mol Biol (Noisy-le-grand); 2022 Feb; 67(5):233-239. PubMed ID: 35818248
[TBL] [Abstract][Full Text] [Related]
17. Distinctive expression of DNA replication factors in squamous cell carcinomas of the lip, face and oral cavity.
Etemad-Moghadam S; Mohammadpour H; Alaeddini M
J Stomatol Oral Maxillofac Surg; 2022 Nov; 123(6):e828-e832. PubMed ID: 35217222
[TBL] [Abstract][Full Text] [Related]
18. Expression of transmembrane protein aquaporin-3 in oral epithelial dysplasia and oral squamous cell carcinoma.
Lekshmy MS; Sivakumar TT; Joseph AP; Varun BR; Mony V; Reshmi A
Oral Surg Oral Med Oral Pathol Oral Radiol; 2021 Feb; 131(2):202-208. PubMed ID: 33187942
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical Expression of Epidermal Growth Factor Receptor (EGFR) in Oral Squamous Cell Carcinoma and Oral Potentially Malignant Disorders.
Aamir R; Rauf F; Iqbal F; Yousuf S; Rehman A; Sheikh AK; Muhammad S
Appl Immunohistochem Mol Morphol; 2024 Mar; 32(3):157-162. PubMed ID: 38268382
[TBL] [Abstract][Full Text] [Related]
20. Histopathological evaluation of minor salivary gland aberrations in oral squamous cell carcinoma.
Bhola R; Narwal A; Kamboj M; Devi A; Anand R; Chatterjee S
J Cancer Res Ther; 2023; 19(2):299-303. PubMed ID: 37313908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
